Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:24:09.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:12:04.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the previously visible study record details for the trial and offering a Home link instead.
    Difference
    18%
    Check dated 2026-09-23T00:52:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an updated version of the study page document.
    Difference
    0.0%
    Check dated 2026-09-15T23:38:48.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6 replacing v3.6.5, indicating a new build of the page. This appears to be a software update rather than a change to study information.
    Difference
    0.0%
    Check dated 2026-09-01T20:19:29.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    An NIH grant/contract entry for 2018 was added to the study's identifiers section. This clarifies the funding source associated with the trial and enhances transparency of sponsorship.
    Difference
    0.0%
    Check dated 2026-08-25T20:17:30.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.